WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of RIGEL PHARMACEUTL (RIGL)

Name RIGEL PHARMACEUTL
Year low 6.57
Year High 10.60
Symbol RIGL
Last trade 7.69
Percentage change -0.52
Volume 60,284
Media Volume (3m) 307,897
PE Ratio N/A
EPS -1.30
Market Cap 549
Media fatt 6
Trend fatt trend fatt graph for RIGEL PHARMACEUTL
Media net income 0
Trend net income trend net income for RIGEL PHARMACEUTL
P / E P / E graph for RIGEL PHARMACEUTL - 0 points 0
EPS EPS graph for RIGEL PHARMACEUTL - 0 points 0
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for RIGEL PHARMACEUTL - 0 points 0
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for RIGEL PHARMACEUTL -  points
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for RIGEL PHARMACEUTL - 0 points 0
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for RIGEL PHARMACEUTL -  points
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for RIGEL PHARMACEUTL -  points
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for RIGEL PHARMACEUTL -  points
NET INC1/NET INC3 net inc1/net inc3 graph for RIGEL PHARMACEUTL - 2 points 2
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for RIGEL PHARMACEUTL - 9 points 9
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for RIGEL PHARMACEUTL - 9 points 9
. . graph for RIGEL PHARMACEUTL -  points
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for RIGEL PHARMACEUTL - 1 points 1
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for RIGEL PHARMACEUTL - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for RIGEL PHARMACEUTL - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for RIGEL PHARMACEUTL - 0 points 0
. . graph for RIGEL PHARMACEUTL -  points
SELL HOLD BUY SELL           HOLD          BUY graph for RIGEL PHARMACEUTL - 0 points 0
SINTESE 21

GRAPHS

max price logarithm graph for RIGEL PHARMACEUTL based on no conditions max volume linear graph for RIGEL PHARMACEUTL based on no conditions

News

Rigel to Webcast Investor Day on October 13, 2011 (Oct 06 - reuters) Beat Up 'Biotechs' To Buy: Part 3 (Sep 27 - reuters) 10 Small-Cap Stocks Bouncing Off Lows With Strong Profitability (Sep 26 - reuters) Better Late Than Never? Maybe. (Sep 06 - reuters) Rigel to Present at Two Upcoming Investor Conferences (Aug 25 - reuters) Rigel Announces Second Quarter 2011 Financial Results (Aug 02 - reuters) » More RIGL.O Market Views (Jul 15 - reuters) Rigel to Present at Wells Fargo Securities Healthcare Conference (Jun 16 - reuters) Building Strength in Biotech - Equity Research on Arena Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. (Jun 13 - reuters) 11 Incredible Dividend Stocks: Abbott Labs (Jun 09 - reuters) Rigel to Present at Jefferies Global Healthcare Conference (Jun 03 - reuters) Rigel Refuels R&D in $130M Offering (May 29 - reuters) Rigel Announces Pricing of Public Offering of Common Stock (May 26 - reuters) Rigel Announces Proposed Public Offering of Common Stock (May 25 - reuters) Losing Biobucks as Pharma Reshuffles Its Deck (May 09 - reuters) » More RIGL.A Market Views (May 07 - reuters) Rigel to Present at Bank of America Merrill Lynch Health Care Conference (May 06 - reuters) Rigel Assumes Development Responsibility for Inhaled Asthma Therapy (May 06 - reuters) UPDATE 1-Rigel says Pfizer returns asthma therapy rights (May 06 - reuters) Rigel Announces First Quarter Financial Results (May 03 - reuters) » More RIGL.DF Market Views (Apr 29 - reuters) Beautiful Efficacy, Wrong Pill (Apr 15 - reuters) Rigel to Present at Stifel Nicolaus Healthcare Conference (Apr 15 - reuters) Rigel Earns Milestone Payments From AstraZeneca (Apr 15 - reuters) Rigel Announces Presentations at Two Investor Conferences (Apr 15 - reuters) Rigel Announces Third Quarter 2010 Financial Results (Apr 15 - reuters) Rigel to Present at Piper Jaffray Health Care Conference (Apr 15 - reuters) Rigel and AstraZeneca Awarded 'Licensing Deal of the Year' by Scrip for Fostamatinib Collaboration (Apr 15 - reuters) » More RIGL.O Market Views (Apr 15 - reuters) Pfizer Needs Rheumatoid Arthritis Drug to Keep Performing (Apr 15 - reuters) Pfizer's Biggest Shot at Lipitor 2.0 (Apr 15 - reuters) The Most Important Thing Affecting Merck (Apr 15 - reuters) Abbott Labs: Growth in All the Wrong Places (Apr 15 - reuters) No Sticking Point Here: Pfizer's Potential Blockbuster Works (Apr 15 - reuters) Rigel Announces Fourth Quarter and Year End 2010 Financial Results (Apr 15 - reuters) Rigel to Present at Three Upcoming Investor Conferences (Apr 15 - reuters) Rigel Announces Participation at Two Investor Conferences (Apr 15 - reuters) Rigel to Present at JP Morgan Healthcare Conference (Apr 15 - reuters) UPDATE 1-U.S. awards $1 billion to small biotechs (Jan 28 - reuters) CORRECTED - CORRECTED-BRIEF-Rigel earns $25 million from Astrazeneca (Jan 28 - reuters) UPDATE 1-Astra starts final-stage trials of arthritis drug (Jan 28 - reuters) Astra learns from failure in arthritis drug race (Jan 28 - reuters) DEALTALK-UPDATE 1-Savient's gout drug nod may trigger bid war (Jan 28 - reuters) DEALTALK-Savient's gout drug nod may trigger bid war (Jan 28 - reuters) CORRECTED - CORRECTED-BRIEF-Rigel earns $25 million from Astrazeneca (Nov 27 - reuters) UPDATE 1-Astra starts final-stage trials of arthritis drug (Nov 27 - reuters) Astra learns from failure in arthritis drug race (Nov 27 - reuters) DEALTALK-UPDATE 1-Savient's gout drug nod may trigger bid war (Nov 27 - reuters) DEALTALK-Savient's gout drug nod may trigger bid war (Nov 27 - reuters) Rigel sees partner for psoriasis drug in 3 months - COO (Nov 27 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY